ArticleBritish journal of pharmacology2020

Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC.

Sundus N Maqbool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.